Cerenome (CNSY) vs Pulsenmore (PLSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cerenome is the larger company by market cap ($14.6 million vs $12.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNSY | PLSM |
|---|---|---|
| Share price | $1.93 | $1.85 |
| Market cap | $14.65M | $12.03M |
| 1-day change | +7.82% | -0.86% |
| YTD return | -84.86% | — |
| 1-year return | -89.28% | — |
| 5-year return | -99.71% | — |
| EPS (TTM) | $-3.36 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.00 | $12.97 |
| 52-week low | $1.49 | $1.82 |
| Distance from 52-week high | -89.84% | -85.74% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1337.82% | — |
| Average volume | 121.94K | 470.76K |
| Shares outstanding | 7.59M | 6.50M |
| Employees | 28 | 71 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cerenome
CNSY stock →Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.
Health Care · Medical/Dental Instruments · 28 employees
About Pulsenmore
PLSM stock →Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe.
Health Care · Medical/Dental Instruments · 71 employees
CNSY vs PLSM FAQ
Which is bigger, Cerenome or Pulsenmore?
Cerenome (CNSY) is larger, with a market capitalization of $14.65M compared with $12.03M for Pulsenmore (PLSM).
Are Cerenome and Pulsenmore in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.